Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer
A Phase 0 Study Evaluating the Systemic Bioavailability and Pharmacodynamic Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer
Sponsor: National Cancer Institute (NCI)
A EARLY_PHASE1 clinical study on Carcinoma in Situ and Dysplasia, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 10 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Sep 2021 — Jul 2024 [monthly]
Completed EARLY_PHASE1
Status: Active Not Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Dec 2019 — Apr 2020 [monthly]
Recruiting EARLY_PHASE1
-
Dec 2018 — Dec 2019 [monthly]
Recruiting EARLY_PHASE1
-
Jun 2018 — Dec 2018 [monthly]
Recruiting EARLY_PHASE1
-
Dec 2017 — Jun 2018 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jun 2017 — Dec 2017 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Apr 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- University of Arizona
For direct contact, visit the study record on ClinicalTrials.gov .